Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 29, 2022--
The "Clinical Microbiology Instruments and Reagents - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Clinical Microbiology Instruments and Reagents Market to Reach $5.8 Billion by 2026
Clinical microbiology holds a prominent role in the field of research and medicine, and support the fight against numerous infectious diseases along with antimicrobial resistance. High prevalence of infectious diseases and sexually transmitted diseases (STDs) will continue to drive the future of automated and rapid tests, as the need for quicker, higher volume and more accurate methods of testing gains significance. Emerging technologies and robust processes have thus transcended microbiology testing to the next-level.
Rising healthcare expenditure, growing need to speed up microbiological testing, scarcity of time, need for rapid QA-QC procedures, and growing imposition of regulations that regulate various production processes are factors that have catalyzed this transformation. The uptake of microbiology is further favored by technological advancements including automated instruments to identify pathogens across laboratories. The trend towards automated instrumentation is aided by the promise of overall cost effectiveness and efficiency. Another driver for the market growth is consolidation of laboratories and rising consumer awareness.
Amid the COVID-19 crisis, the global market for Clinical Microbiology Instruments and Reagents estimated at US$4.5 Billion in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2026, growing at a CAGR of 6.4% over the analysis period.
The U.S. Market is Estimated at $1.7 Billion in 2022, While China is Forecast to Reach $284.1 Million by 2026
The Clinical Microbiology Instruments and Reagents market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$284.1 Million by the year 2026 trailing a CAGR of 7.7% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 6.3% respectively over the analysis period.
Select Competitors (Total 59 Featured):
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/r/1ncybr
View source version on businesswire.com:https://www.businesswire.com/news/home/20220929005758/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: RESEARCH TECHNOLOGY MEDICAL DEVICES INFECTIOUS DISEASES CLINICAL TRIALS BIOTECHNOLOGY PHARMACEUTICAL ROBOTICS HEALTH SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/29/2022 11:33 AM/DISC: 09/29/2022 11:33 AM
http://www.businesswire.com/news/home/20220929005758/en